Expression of human cathepsin K in Pichia pastoris and preliminary crystallographic studies of an inhibitor complex

Protein Science

Volumn 6, Issue 4, 1997, Pages 919-921

  Linnevers, Christopher J ^a   McGrath, Mary E ^a   Armstrong, Randy ^a   Mistry, Firoz R ^a   Barnes, Michael G ^a   Klaus, Jeffrey L ^a   Palmer, James T ^a   Katz, Bradley A ^a   Brömme, Dieter ^a  

^a Arris Pharmaceuticals   (United States)

Author keywords

cysteine protease; osteoclast; osteopetrosis; structure based drug design; vinyl sulfone

Indexed keywords

CATHEPSIN; CYSTEINE PROTEINASE;

ALBERS SCHOENBERG DISEASE; AMINO ACID SEQUENCE; ARTICLE; ENDOMYCETALES; ENZYME ACTIVATION; ENZYME PURIFICATION; GENE EXPRESSION; GLYCOSYLATION; OSTEOCLAST; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PROCESSING; X RAY CRYSTALLOGRAPHY;

EID: 0030949461     PISSN: 09618368     EISSN: None     Source Type: Journal    
DOI: 10.1002/pro.5560060421     Document Type: Article

References (25)

1. Bossard MJ, Tomaszek TA, Thompson SK, Amegadzie BY, Hanning CR, Jones C, Kurdyla JT, McNulty DE, Drake FH, Gowen M, Levy MA. 1996. Proteolytic activity of human osteocla cathepsin K. J Biol Chem 271:12517-12524.
2. Brömme D, Klaus JL, Okamoto K, Rasnick D, Palmer JT. 1996. Peptidyl vinyl sulphones: A new class of potent and selective cysteine protease inhibitors: S2P2 specificity of human cathepsin O2 in comparison with cathepsins S and L. Biochem J 315:85-89.
3. Brömme D, Okamoto K. 1995. Human cathepsin O2: A novel cysteine protease highly expressed in osteoclastoma and ovary. Biol Chem Hoppe-Seyler 376:379-384.
4. Brömme D, Okamoto K, Wang BB, Biroc S. 1996. Human cathepsin O2, a matrix protein-degrading cysteine protease expressed in osteoclasts. J Biol Chem 271:2126-2132.
5. Brömme D, Schmidt BF. 1997. Functional expression of recombinant proteases. In: Sterchi E, Stöcker W, eds. Proteolytic enzymes - A lab manual. Heidelberg: Springer Verlag. Forthcoming.
6. Coulombe R, Grochulski P, Sivaraman J, Menard R, Mort JS, Cygler, M. 1996. Structure of human procathepsin L reveals the molecular basis of inhibition by the prosegment. EMBO 15:5492-5503.
7. Cregg JM, Vedvick TS, Raschke WC. 1993. Recent advances in the expression of foreign genes in Pichia pastoris. Bio/Technology 11:30238-30242.
8. Delaisse J-M, Boyde A, Maconnachie E, Ali NN, Sear CHJ, Eeckhout Y, Vaes G, Jones SJ. 1987. The effects of inhibitors of cysteine-proteinases and collagenase on the resorptive activity of isolated osteoclasts. Bone 8:305-313.
9. Drake FH, Dodds RA, James IE, Connor JR, Debouck C, Richardson S, Lee-Rykaczewski E, Coleman L, Rieman D, Barthlow R, Hastings G, Gowen M. 1996. Cathepsin K, but not cathpsins B, L, or S, is abundantly expressed in human osteoclasts. J Biol Chem 271:12511-12516.
10. Everts V, Beertsen W, Schröder R. 1988. Effects of proteinase inhibitors leupeptin and E-64 on osteoclastic bone resorption. Calcif Tissue Int 43:172-178.
11. Gelb BD, Edelson JG, Desnick RJ. 1995. Linkage of pycnodysostosis to chromosome 1q21 by homozygosity mapping. Nat Genet 10:235-237.
12. Gelb BD, Shi G-P, Chapman HA, Desnick RJ. 1996. Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency. Science 273:1236-1238.
13. Hill PA, Buttle DJ, Jones SJ, Boyde A, Murata A, Reynolds JJ, Meikle MC. 1994. Inhibition of bone resorption by selective inactivators of cysteine proteinases. J Cell Biochem 56:118-130.
14. Inaoka T, Bilbe G, Ishibashi O, Tezuka K, Kumegawa M, Kokubo T. 1995. Molecular cloning of cDNA for cathepsin K: A novel cysteine protease predominantly expressed in bone. Biochem Biophys Res Commun 206:89-96.
15. InVitrogen Corporation. 1995. A manual of methods for expression of recombinant proteins in Pichia, Version 1.9.
16. Jancarik J, Kim S-H. 1991. Sparse matrix sampling: A screening method for crystallization of proteins. J Appl Crystallogr 24:409-411.
17. Kunkel TA, Roberts JD, Zakour RA. 1987. Rapid and specific site-specific mutagenesi.s without phenotypic selection. Methods Enzymol 154:367-382.
18. Li YP, Alexander MB, Wucherpfennig AL, Yelick P, Chen W, Stashenko P. 1995. Cloning and complete coding sequence of a novel human cathepsin expressed in giant cells of osteoclastomas. J Bone Mineral Res 10:1197-1202.
19. Liao JC, Lenney JF. 1984. High molecular weight cysteine proteinases from human tissue. Biochem Biophys Res Commun 124:909-916.
20. Matthews BW. 1968. Solvent content of protein crystals. J Mol Biol 33:491-497.
21. McGrath ME, Eakin AE, Engel J, McKerrow JH, Craik CS, Fletterick RJ. 1995. The crystal structure of cruzain: A therapeutic target for Chagas' disease. J Mol Biol 247:251-259.
22. Palmer JT, Rasnick D, Klaus JL. 1995. Vinyl sulfones as mechanism-based cysteine protease inhibitors. J Med Chem 38:3193-3196.
23. Sedano HD, Gorlin RJ. 1968. Pycnodysostosis. Clinical and genetic considerations. Am J Dis Child 116:70-77.
24. Shi G-P, Chapman H, Bhairi S, DeLeeuw C, Reddy VY, Weiss SJ. 1995. Molecular cloning of human cathepsin O, a novel endoproteinase and homologue of rabbit OC2. FEBS Lett 357:129-134.
25. Tezuka K, Tezuka Y, Maejima A, Sato T, Nemoto K, Kamioka H, Hakeda Y, Kumegawa M. 1994. Molecular cloning of a possible cysteine proteinase predominantly expressed in osteoclasts. J Biol Chem 269:1106-1109.